Abstract
Type I diabetes, also known as insulin-dependent diabetes mellitus (IDDM) results from the destruction of insulin-producing pancreatic β cells by a progressive β cell-specific autoimmune process. The pathogenesis of autoimmune IDDM has been extensively studied for the past two decades using animal models such as the non-obese diabetic (NOD) mouse and the Bio-Breeding (BB) rat. However, the initial events that trigger the immune responses leading to the selective destruction of the β cells are poorly understood. It is thought that β cell auto-antigens are involved in the triggering of β cell-specific autoimmunity. Among a dozen putative β cell autoantigens, glutamic acid decarboxylase (GAD) has been proposed as perhaps the strongest candidate in both humans and the NOD mouse. In the NOD mouse, GAD, as compared with other β cell autoantigens, provokes the earliest T cell proliferative response. The suppression of GAD expression in the β cells results in the prevention of autoimmune diabetes in NOD mice. In addition, the major populations of cells infiltrating the islets during the early stage of insulitis in BB rats and NOD mice are macrophages and dendritic cells. The inactivation of macrophages in NOD mice results in the prevention of T cell mediated autoimmune diabetes. Macrophages are primary contributors to the creation of the immune environment conducive to the development and activation of β cell-specific Th1-type CD4+ T cells and CD8+ cytotoxic T cells that cause autoimmune diabetes in NOD mice. CD4+ and CD8+ T cells are both believed to be important for the destruction of β cells. These cells, as final effectors, can kill the insulin-producing β cells by the induction of apoptosis. In addition, CD8+ cytotoxic T cells release granzyme and cytolysin (perforin), which are also toxic to β cells. In this way, macrophages, CD4+ T cells and CD8+ T cells act synergistically to kill the β ceils in conjunction with β cell autoantigens and MHC class I and class II antigens, resulting in the onset of sautoimmune type I diabetes.
Similar content being viewed by others
References cited
Amano, K. and Yoon, J. W., Studies on autoimmunity for initiation of beta-cell destruction: V: Decrease of macrophage dependent T-effector cells and natural killer cytotoxicity in silica-treated BB rats.Diabetes, 39, 590–596, (1990).
Appels, B., Burkart, V., Kantwerk-Funke, M., Funda, J., Kolb-Bachofen, V. and Kolb, H., Spontaneous cytotoxicity of macrophages against pancreatic islet cells.J Immunol., 142, 803–808, (1989).
Arden, S. D., Roep, B. O., Neophytou, P. I., Usac, E. F., Duinkerken, C., de Vries, R. R. P. and Hutton, J. D., Imogen 38: a novel 38-kD islet mitochondrial auto-antigen recognized by T cells from a newly diagnosed type I diabetic patient.J Clin Invest., 97, 551–561 (1996).
Asayama, K., Kooy, N. W. and Burr, I. M., Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets; decrease of islet manganosuperoxide dismutase.J Lab Clin Med., 107, 4559–4564 (1986).
Atkinson, M. A., Bowman, M. A., Kao, K. J., Campbell, L., Dush, R. J., Shah, S. C., Simell, O. and Maclaren, N. K., Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes.New Engl J Med., 329, 1853–1858 (1993).
Atkinson, M. A., McLaren, N. K., Scharp, D., Lacy, P. E. and Reiiey, W. J., 64.000 Mr autoantibodie as predictors of insulin-dependent diabetes.Lancet, 335, 1357–1360 (1990).
Bach, J. F. Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulationJ Autoimmun., 8, 439–463 (1995).
Baekkeskov, S., Jan-Aanstoot, H., Christgau, S., Reetz, A., Solimena, M., Cascalho, F., Folli, F., Richter-Olesen, H. and DeCamilli, P., Identification of the 64K auto-antigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.Nature, (Lond.), 347, 151–156 (1990).
Baekkeskov, S., Landin, M., Kristensen, J. K., Srikanta, S., Bruining, G. J., Mandrup-Poulsen, T., deBeaufort, C., Sveldner, J. S., Einsenbarth, G. S., Lindgren, F., Sundquist, G. and Lernmark, A., Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.J Clin Invest., 79, 926–934 (1987).
Baekkeskov, S., Nielsen, J. H., Marner, B., Bilde, T., Ludvigsson, J. and Lemmark, A., Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.Nature, (Lond.), 298, 167–169 (1982)
Bieg, S., Seissler, J., Herberg, L., Northemann, W. and Scherbaum, W. A., GAD65 is recognized by T-cells, but not by antibodies from NOD mice.Autoimmunity, 17, 189–194 (1994).
Birk, O. S., Elias, D., Weiss, A.S., Rosen, A., Van der Zee, R., Walker, M. D. and Cohen, I. R., NOD mouse diabetes: The ubiquitous mouse HSP60 is a β cell target antigen of autoimmune T cells,J Autoimmun., 9, 159–166 (1996).
Bonifacio, E., Bingley, P. J., Shattock, M., Dean, B. M., Dunger, D., Gale, E. A. and Bottazzo, G. F., Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.Lancet, 335, 147–149 (1990).
Bonifacio, E., Lampasona, V., Genovese, S., Ferrari, M. and Bosi, E., Identification of protein tyrosine phosph-atase-like IA-2 (islet cell antigen 512) as the insulin dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.J Immunol., 155, 5419–5426 (1995).
Bottazzo, G. F., Florin-Christensen, A. and Doniach, D., Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency.Lancet, 2, 1279–1283 (1974).
Bridgett, M., Cetkovic-Cvrlje, M., ORourke, R., Shi, Y., Narayanswami, S., Lambert, J., Ramiya, V., Baekkeskov, S. and Leiter, E. H., Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells.Diabetes, 47, 1848–1856. (1998).
Cameron, M. J., Arreaza, G. A., Zucker, P., Chensue, S. W., Strieter, R. M., Chakrabarti, S. and Delovitch, T. L., IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.J Immunol., 159, 4686–4692 (1997).
Castano, L., Russo, E., Zhou, L., Lipes, M. A. and Eisenbarth, G., Identification and cloning of a granule autoantigen (Carboxypeptidase-H) associated with type I diabetes.J Clin Endocrinol & Metab., 73, 1197–1201 (1991).
Chen, S. L., Whiteley, P. J., Freed, D. C., Rothbard, J. B., Peterson, L. B. and Wicker, L. S., Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.J Autoimmun., 7, 635–641 (1994).
Chervonsky, A. V., Wang, Y., Wong, F. S., Visinitin, I., Flavell, R. A., Janeway Jr, C. A. and Matis, L. A., The role of Fas in autoimmune diabetes.Cell, 89,17–24 (1997).
Christianson, S. W., Shultz, L. D. and Leiter, E. H., Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD. NON-Thy-1a donors.Diabetes, 42, 44–55 (1993).
Christie, M. R., Genovese, S., Cassidy, D., Bosi, E., Brown, T. J., Lai, M., Bonifacio, E. and Bottazzo, C. F., Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.Diabetes, 43, 1254–1259 (1994).
Corbett, J. A. and McDaniel, M. L., Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic interventions in IDDM.Diabetes, 41, 897–903 (1992).
Daniel, D., Gill, R. G., Schloot, N. and Wegmann, D., Epitope specificity cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from the NOD mouse.Eur J Immunol., 25, 1056–1062 (1994).
Dardenne, M., Lepault, F., Bendelac, A. and Bach, J. F., Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning.Eur J Immunol, 19, 889–895 (1989).
DeSilva, M. G., Jun, H. S., Yoon, J. W., Notkins, A. L. and Lan, M. S., Autoantibodies to IA-2 not detected in NOD mice or BB rats.Diabetologia, 39, 1237–1238 (1996).
Debray-Sachs, M., Carnaud, C., Biotard, C., Cohen, H., Gresser, I., Bedossa, P. and Bach, J. F., Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ.J Autoimmunity., 4, 237–248 (1991).
Delovitch, T. L. and Singh, B., The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD.Immunity, 7, 727–738 (1997).
Dilorenzo, T. P., Graser, R. T., Ono, T., Christiansen, G. J., Chapman, H. D., Roopenian, D. C., Nathenson, S. G. and Serreze, D. V., Major histocompatibility complex class l-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor a chain gene rearrangement.Proc Natl Acad Sci., 95, 12538–12543 (1998).
Edouard, P., Hiserodt, J. C., Plamondon, C. and Poussier, P., CD8+ T-cells are required for adoptive transfer of the BB rat diabetic syndrome.Diabetes, 42, 390–397 (1993).
Elias, D., Markovits, D., Reshef, T., Van der Zee, R. and Cohen, I. R., Induction and therapy of autoimmune diabetes in the non-obese diabetic mouse by a 65-kDa heat shock protein.Proc Natl Acad Sci., USA, 87, 1576–1580 (1990).
Elliot, J. F., Qin, H. Y., Bhatti, S., Smith, D. K., Singh, B. K., Dillon, T., Lauzon, J. and Singh, B., Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.Diabetesm, 43, 1494–1499 (1994).
Faust, A., Kleemann, R., Rothe, H. and Kolb, H., Role of macrophages and cytokines in β-cell death. In Shafri E, editor.Lessons from Animal Diabetes VI, Birkhauser, Boston, Cambridge, pp. 47–56 (1996).
French, M. B., Allison, J., Cram, D. S., Thomas, H. E., Dempsey-Collier, M., Silva, A., Georgiou, H. M., Kay, T. W., Harrison, L. C. and Lew, A. M., Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes, 46, 34–39 (1997).
Geng, L., Solimena, M., Flavell, R. A., Sherwin, R. S. and Hayday, A. C., Widespread expression of an auto-antigen GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.Proc Natl Acad Sci., USA, 95, 10055–10060 (1998).
Hultgren, B., Huang, X., Dybdal, N. and Stewart, T. A., Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice.Diabetes, 45, 812–817 (1996).
Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, H., Miyagawa, J., Namba, M., Makino, S., Nagata, S., Kono, N. and Matsuzawa, Y., Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.J Exp Med., 186, 613–618 (1997).
Jasen, A., Homo-Delarche, R., Hooijkaas, H., Leenen, P. J., Dardenne, M. and Drexhage, H. A., Immuno-histochemical characterization of monocyte-macrophages and dendritic cells involved in the initiation of insulitis and beta-cell destruction in NOD mice.Diabetes, 43, 667–675 (1994).
Johnson, T. H., Crider, B. P., McCorkle, K., Alford, M. and Unger, R. H., Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.New Engl J Med., 322, 653–659 (1990).
Jones, D. B., Hunter, N. R. and Duff, G. W., Heat shock protein 65 as a β cell antigen of insulin-dependent diabetes.Lancet, 335, 583–585 (1990).
Jun, H. S., Yoon, C. S., Zbytnuik, L., van Rooijen, N. and Yoon, J. W., The role of macrophages in T cell-mediated autoimmune type 1 diabetes in NOD mice.J Exp Med., 189, 347–358 (1999).
Kagi, D., Odermatt, B., Seiler, P., Zinkernagel, R. M., Mak, T. W. and Hengartner, H., Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.J Exp Med., 186, 989–997 (1997).
Karges, W., Hammond-McKibben, D., Caedigk, R., Shi-buya, N., Cheung, R. and Dosch, H. M., Loss of self-tolerance to ICA69 in nonobese diabetic mice.Diabetes, 46, 1548–1556 (1997).
Karjalainen, J., Martin, J. M., Knip, M., Ilonen, J., Robinson, B. H., Savilahti, E., Akerblom, H. and Dosch, H. M., A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus.N Engl J Med., 327, 302–307 (1992).
Karounos, D. C. and Thomas, J. W., Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM.Diabetes, 39, 1085–1090 (1990).
Karounos, D. C., Wolinsky, J. S., Gillard, B. K. and Thomas, J. W., Molecular mimicry in type I diabetes: An antigenic determinant on a rubella virus protein is shared with a 52kD beta cell autoantigen.Diabetes, 39, 96a (Abstr.) (1990).
Katz, J., Benoist, C. and Mathis, D., Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.Eur j Immunol., 23, 3358–3360 (1993).
Kaufman, D., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J. and Lehmann, P. V., Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.Nature, 366, 69–72 (1993).
Ko, I. Y., Ihm, S. H. and Yoon, J. W., Studies on autoimmunity for initiation of beta-cell destruction VIII. Pancreatic beta cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats.Diabetologia, 34, 548–554 (1991).
Ko, I. Y., Jun, H. S., Kim, G. S. and Yoon, J. W., Studies on autoimmunity for initiation of beta-cell destruction X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the BB rat.Diabetologia, 37, 460–465 (1994).
Koevary, S., Rossini, A. A., Stroller, W. and Chick, W., Passive transfer of diabetes in the BB/W rat.Science, 220, 727–728 (1983).
Kolb, H. G., Kantwerk, U., Treichel, T., Kurner, U., Kiesel, T. and Hoppe, V., Kolb-Bachofen., Prospective analysis of islet lesions in BB rats.Diabetologia, 29(Suppl. 1), A559 (1986).
Kurrer, M. O., Pakala, S. V., Hanson, H. L. and Katz, J. D., β cell apoptosis in T cell-mediated autoimmune diabetes.Proc Natl Acad Sci USA., 94, 213–218 (1997).
Lan, M. S., Wasserfall, C., Maclaren, N. K. and Notkins, A. L., IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in IDDM.Proc Natl Acad Sci USA., 93, 6367–6370 (1996).
Lee, K. U., Amano, K. and Yoon, J. W., Evidence for initial involvement of macrophage in development of insulitis in NOD mice.Diabetes, 37, 989–991 (1988a).
Lee, K. U., Pak, C. Y., Amano, K. and Yoon, J. W., Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the depletion of macrophages.Diabetologia, 31, 400–402 (1988b).
Lernmark, A., Barmeier, H., Dube, S., Hagopian, W., Kar-Isen, A. E., Markholst, H., Wilson, C. and Wassmuth, R., Molecular analysis of the pathogenesis of beta cell destruction in insulin-dependent diabetes mellitus.Western J Med., 153, 499–502 (1990).
Like, A. A., Biron, C. A., Weringer, E. J., Byman, K., Sroczynsaki, E. and Guberski, D. L., Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T-lymphocytes or natural killer cells.J Exp Med., 164, 1145–1159 (1986).
Like, A. A., Kislauskis, E., Williams, R. M. and Rossini, A. A., Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat.Science, 216, 644–646 (1982).
Lim, H. W., Huang, Q. Q., Yoon, C. S., Jun, H. S., Hirasawa, K. and Yoon, J. W., Complete prevention of autoimmune IDDM by β-cell-specific suppression of GAD expression in transgenic NOD mice.Diabetes, 47(Suppl. 1), A211 (1998).
MacCuish, A. C., Irvine, W. J., Barnes, E. W. and Duncan, L. J., Antibodies to pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease.Lancet, 2, 1529–1531 (1974).
Makino, S., Harada, M., Kishimoto, Y. and Hayashi, Y., Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background.Exp Anim., 35, 495–499 (1986).
Malaisse, W. J., Malaisse-Lagae, F., Sener, A. and Pipeleers, D. G., Determinants of the selective toxicity of alloxan to the pancreatic β cell.Proc Natl Acad Sci., USA, 79, 927–930 (1982).
Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C.. and Nerup, J., Human tumor-necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta cell-cytotoxicity.J Immunol., 139, 4077–4082 (1987).
Maron, R., Elias, D., deJong, H., Bruining, J., van Rood, J. J., Schlechter, Y. and Cohen, I. R., Autoantibodies to the insulin receptor in juvenile onset diabetes.Nature, 303, 817–819 (1984).
Martin, J. M., Trink, B., Daneman, D., Dosch, H. M. and Robinson, B. H., Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM).Ann Med., 23, 447–452 (1991).
Miller, B. J., Appel, M. C., O'Neill, J. J. and Wicker, L. S., Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.J Immunol., 140, 52–58 (1988).
Mueller, R., Krahl, T. and Sarvetnick, N., Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice,J Exp Med., 1093–1099 (1996).
Nagata, M., Santamaria, P., Kawamura, T., Utsugi, T. and Yoon, J. W., Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta cells in NOD mice.J Immunol., 152, 2042–2050 (1994).
Nagata, M. and Yoon, J. W., Studies on autoimmunity for initiation of beta cell destruction: IX. Electron microscopic evidence on a distinct difference in the destruction of beta cells between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice.Diabetes, 41, 998–1008 (1992).
Nayak, R. C., Omar, M. A. K., Rabizadeh, A., Srikanta, S. and Eisenbarth, G. S., Cytoplasmic islet cell antibodies: Evidence that the target antigen is a sialoglycocon-jugate.Diabetes, 34, 617–619 (1985).
Nerup, J., Mandrup-Poulserj, T., Molvig, J., Helqvist, S., Wogensen, L., Egeberg, J., Mechanisms of pancreatic β cell destruction in type 1 diabetes.Diabetes Care, 11 (suppl 1), 16–23 (1988).
Ogawa, M., Maruyama, T., Hasegawa, T., Kanaya, T., Kobayashi, F., Tochino, Y. and Uda, H., The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice.Biomed Res, 6, 103–106 (1985).
Oschilewski, U., Kiesel, U. and Kolb, H., Administration of silica prevents diabetes in BB rats.Diabetes, 34, 197–199 (1985).
Pak, C. Y., Cha, C. Y., Rajotte, R. V., McArthur, R. G. and Yoon, J. W., Human pancreatic islet cell-specific 38kD autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody.Diabetologia, 33, 569–572 (1990).
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tapati, O., Raghu, P. and Pauquett, T. L., Insulin autoantibodies in insulin-dependent diabetes before insulin treatment.Science, 222, 1337–1338 (1983).
Pankewycz, O. G., Guan, J. X. and Benedict, J. F., Cytokines as mediators of autoimmune diabetes and diabetic complications.Endocrin Rev., 16(2), 164–176 (1995).
Peitropaolo, M., Castano, L., Babu, S., Buelow, R., Kuo, Y. L., Martin, S., Martin, A., Powers, A. C., Prochazka, M., Naggert, J., Leither, E. H. and Eisenbarth, G. S., Islet cell autoantigen 69kD (ICA 69). Molecular cloning and characterization of a novel diabetes-associated autoantigen.J Clin Invest., 92, 359–371 (1993).
Pennline, K. J., Roque-Gaffney, E. and Monahan, M., Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse.Clin Immunol Immunopathol, 71, 169–175 (1994).
Peterson, J. D. and Haskins, K., Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.Diabetes, 45, 328–336 (1996).
Pukel, C., Baquerizo, H. and Rabinovitch, A., Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin-1.Diabetes, 37, 133–136 (1988).
Rabinovitch, A., Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?Diabetes, 43, 613–621 (1994).
Roep, B. O., Arden, S., de Vries, R. R. P. and Hutton, J., T-cell clones from a type I diabetes patient respond to insulin secretory proteins.Nature, (Lond.), 345, 632–634 (1990).
Rossini, A. A., Greiner, D. L., Friedman, H. R. and Mordes, J. P., Immunopathogenesis of diabetes mellitus.Diabetes Reviews, 1, 43–75 (1993).
Sarvetnick, N., Liggitt, D., Pitts, S., Hansen, S. and Stewart, T., Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.Cell, 52, 773–782 (1998).
Schmidt, D., Verdaguer, J., Averiii, N. and Santamari, P., A mechanism for the major histocompativility complex-linked resistance to autoimmunity.J Exp Med., 186, 1059–1075 (1997).
Serreze, D. V., Leiter, E., Kuff, E. L., Jardieu, P. and Ishizaka, K., Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice.Diabetes, 37, 351–358 (1988).
Thivolet, C., Bendelac, A., Bedossa, P., Bach, J. F. and Carnaud, C., CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent.J Immunol., 146, 85–88 (1991).
Tisch, R. and McDevitt, H., Insulin-dependent diabetes mellitus.Cell, 85, 291–297 (1996).
Unuaue, E. R., Antigen-presenting function of the macrophage.Ann Rev Immunol., 2, 395–428 (1984).
Verdaguer, J., Yoon, J. W., Averiii, N., Utsugi, T., Park, B. J. and Santamaria, R., Acceleration of diabetes in NOD mice expressing beta cell-cytotoxic T cell-derived TcRβ transgene.J Immunol, 157, 4726–4735 (1996).
Verge, C. F. and Eisenbarth, G. S., Prediction of type I diabetes the natural history of the prediabetic period. In: Eisenbarth, G. s., Lafferty, K. J., editors.Type I Diabetes: Molecular, Cellular and Clinical Immunology, Oxford University Press, New York, pp. 230–258 (1996).
Voorbij, H. A. M., Jeucken, P. H. M., Kabel, P. J., DeHaan, M. and Drexhage, H. A., Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats.Diabetes, 38,1623–1629 (1989).
Walker, R., Bone, A. J., Cooke, A. and Baird, J. D., Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats: possible role for macrophages in pathogenesis of IDDM.Diabetes, 37, 1301–1304 (1988).
Wang, B., Gonzales, A., Hglund, P., Katz, J. D., Benoist, C. and Mathis, D., lnterleukin-4 deficiency does not exacerbate disease in NOD mice.Diabetes, 47, 1207–1211 (1998).
Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., Podolin, P. L., Zijlstra, M., Jaenisch, R. and Peterson, L. B., Beta2-microglobulin-deficient NOD mice do not develop insulitis or diabetes.Diabetes, 43, 500–504 (1994).
Wilkin, T. J. and Nicholson, S., Autoantibodies against human insulin.Br Med J., 288, 349–352, (1984).
Wong, F. S., Wen, L., Visintin, I., Flavell, R. A. and Jane-way Jr, C. A., CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in the absence of CD4 cells.J Exp Med., 183, 67–76 (1996).
Yagi, H., Matsumoto, M., Kunimoto, K., Kawaguchi, J., Makino, S. and Harada, M., Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.Eur J Immunol., 22, 2387–2393 (1992).
Yoon, J. W. and Jun, H. S., Insulin-dependent diabetes mellitus. In: Roitt IM and Delves PJ, editors.Encyclopedia of Immunology, Second Edition. London, UK: Academic Press Ltd., pp. 1390–1398 (1998).
Yoon, J. W., Yoon, C. S., Lim, H. W., Huang, Q. Kang, Y., Pyun, K. H., Hirasawa, K., Sherwin, R. S. and Jun, H. S., Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells.Science, 284, 1183–1187 (1998).
Zekzer, D., Wong, F. S., Ayalon, O., Millet, I., Altieri, M., Shintani, S., Solimena, M. and Sherwin, R. S., GAD-reactive CD4+ Th1 cells induce diabetes in NOD/ SCID mice.J Clin Invest., 101, 68–73 (1998).
Zhang, Z. J., Davidsen, L., Eisenbarth, G. S., Weiner, H. L. and Weiner, R. S., Suppression of diabetes in nonobese mdiabetic mice by oral administration of porcine insulin.Proc Natl Acad Sci., USA., 88, 10252–10256 (1991).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, JW., Jun, HS. Cellular and molecular roles of β cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes. Arch Pharm Res 22, 437–447 (1999). https://doi.org/10.1007/BF02979150
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02979150